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Abstract
Fibroblast proliferation and migration play important roles in wound healing. bFGF is known to promote both fibroblast
proliferation and migration during the process of wound healing. However, the signal transduction of bFGF-induced fibroblast
migration is still unclear, because bFGF can affect both proliferation and migration. Herein, we investigated the effect of bFGF on
fibroblast migration regardless of its effect on fibroblast proliferation. We noticed involvement of the small GTPases of the Rho
family, PI3-kinase, and JNK. bFGF activated RhoA, Rac1, PI3-kinase, and JNK in cultured fibroblasts. Inhibition of RhoA did not block
bFGF-induced fibroblast migration,whereas inhibition of Rac1, PI3-kinase, or JNK blockedthefibroblast migration significantly.PI3-
kinase-inhibited cells down-regulated the activities of Rac1 and JNK, and Rac1-inhibited cells down-regulated JNK activity,
suggesting that PI3-kinase is upstream of Rac1 and that JNK is downstream of Rac1. Thus, we concluded that PI3-kinase, Rac1, and
JNK were essential for bFGF-induced fibroblast migration, which is a novel pathway of bFGF-induced cell migration.
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Introduction
The process of wound healing involves coordinated efforts of
several cell types including keratinocytes, fibroblasts, endothelial cells,
macrophages, and platelets. The migration, infiltration, proliferation,
and differentiation of these cells cause an inflammatory response,
which is essential for the formation of new tissue and lead to wound
closure [1]. In this process, especially, fibroblast proliferation and
migration play important roles in the formation of granulation tissue
and wound closure.
Cell migration is indispensable for wound repair. Cell migration
can be divided into multi-step cyclic processes. The basic
migratory cycle includes extension of a protrusion, formation of
stable attachments near the leading edge of the protrusion,
translocation of the cell body forward, release of adhesions and
retraction at the cell rear [2–4]. These steps require remodeling of
the actin cytoskeleton, and the small GTPases of the Rho family
are key regulators of these cytoskeletal dynamics. At the leading
edge of the migrating cells, Rac1 induces the formation of
lamellipodial protrusions via activation of the Wave complex [5],
which provides the driving force of cell movements [6–8]. Cdc42 is
involved in establishing polarity [9], and inhibition of Cdc42 can
disrupt the directionality of migration [10], suggesting that Cdc42
can also contribute to the cell movement. On the other hand,
RhoA promotes the contraction of actin stress fibers to generate
contractile forces [11,12]. However, RhoA is activated not only at
the rear of migrating cells, but also at the front, implying that
RhoA cooperates with Rac1 and Cdc42 to induce membrane
ruffles [13].
The process of wound healing is regulated by numerous growth
factors, such as epidermal growth factor (EGF), transforming
growth factor-b, vascular endothelial growth factor (VEGF),
platelet-derived growth factor (PDGF), and basic fibroblast growth
factor (bFGF). bFGF is a member of a large FGF family of
structurally related proteins that bind heparin or heparan sulfate
and modulate the growth, differentiation, migration, and survival
of a wide variety of cell types [14]. FGF binds to the different
isoforms encoded by the four receptor tyrosine kinases designated
FGFR1-4, and also binds to heparin or heparan sulfate
proteoglycans. FGF-stimulation leads to recruitment of multiple
Grb2/Sos complexes resulting in activation of the Ras/MAPK
signaling pathway [15], and the Ras/MAPK signaling pathway
plays an important role in bFGF-induced cell proliferation.
Regarding the role of the fibroblasts in the process of wound
healing, bFGF is known to promote both proliferation and migration.
Schreier et al. investigated the relative role of bFGF in migration and
proliferation of fibroblasts in an in-vitro model of wound healing [16].
ItwasnecessarytoexcludetheeffectofbFGF on proliferationin their
study to analyze the effect of bFGF on migration alone.
In the present study, we investigated the effect of bFGF on
fibroblast migration during wound healing regardless of its effects
on fibroblast proliferation, and we noticed signal transduction
involving the small GTPases of the Rho family.
Results
Mitomycin-C blocked fibroblast proliferation
bFGF reportedly promotes fibroblast proliferation. Proliferation
itself can promote wound healing [17], and therefore, it is
PLoS ONE | www.plosone.org 1 August 2010 | Volume 5 | Issue 8 | e12228necessary to exclude the effect on proliferation when evaluating
bFGF-induced migratory ability in wound healing. Some
investigators examined the effect of bFGF on fibroblast migration
[18–21]. However, they did not exclude the effect on bFGF-
induced fibroblast proliferation. Accordingly, we performed
subsequent assays in the presence of mitomycin-C to block cell
proliferation [16,22], which enabled evaluation of cell migration
with treatment of bFGF, while excluding any influence of cell
proliferation. Firstly, to determine the optimal concentration of
mitomycin-C to block cell proliferation, while not damaging the
cell viability, we investigated the changes of fibroblast cell number
24 h after treatment with various concentrations of mitomycin-C.
As shown in Fig. 1A, without bFGF, mitomycin-C at 1 mg/ml did
not block cell proliferation. Mitomycin-C at 5 mg/ml completely
inhibited cell proliferation, but did not decrease the cell number.
Moreover, even in the presence of bFGF, mitomycin-C at 5 mg/ml
blocked fibroblast proliferation (Fig. 1B). We therefore considered
5 mg/ml as the optimal concentration of mitomycin-C to block cell
proliferation, and we performed all of the subsequent wound
healing assays in the presence of mitomycin-C at 5 mg/ml.
bFGF promoted fibroblast migration and induced
lamellipodial extension
To determine the optimal concentration of bFGF for fibroblast
migration, we performed a wound healing assay for 24 h in the
presence of mitomycin-C at 5 mg/ml with treatments by various
concentrations of bFGF; namely, at 0, 10, 100, and 1000 ng/ml
(Figs. 2A and B).
As shown in Fig. 2B, the cells treated with bFGF at 10 ng/ml
showed an increased the migration rate during 12 h
(15.6361.04 mm/h) and 24 h (14.5860.68 mm/h) as compared
to the cells not treated with bFGF during 12 h (5.7360.52 mm/h)
and 24 h (5.3460.36 mm/h) (see Movie S1 in the supporting
information). The cells treated with bFGF at 100 ng/ml showed
an increased the migration rate during 12 h (25.0061.11 mm/h)
and 24 h (19.7960.39 mm/h) (see Movie S2 in the supporting
information). The cells treated with bFGF at 1000 ng/ml showed
an increased the migration rate during 12 h (25.5260.94 mm/h)
and 24 h (20.1860.27 mm/h). These data indicated that bFGF at
100 or 1000 ng/ml had the greatest impact on promotion of
fibroblast migration while not having any effect on fibroblast
proliferation. We adopted 100 ng/ml of bFGF for the subsequent
wound healing assays to promote fibroblast migration.
Migrating cells require remodeling of the actin cytoskeleton
[2,4,23]. Therefore, we assessed the effect of bFGF on remodeling
of the actin cytoskeleton by immunostaining the cells with
rhodamine-conjugated phalloidin. As shown in Fig. 2C, the
bFGF-treated fibroblasts significantly developed lamellipodial
extension in the scratch wound. Lamellipodial extension was
quantified by summing the length of the outer margins of all
lamellipodium in individual cells, and was expressed as a
proportion of the total perimeter of each cell (lamellipodial index),
as described by Verma et al. [24]. bFGF induced lamellipodial
extension at 1 h (12.1761.30%), 6 h (20.3361.91%), and 12 h
(17.3361.78%) after wounding as compared to the non-treated
fibroblasts at 1 h (3.8360.89%), 6 h (6.1761.21%) and 12 h
(5.5060.85%) (Fig. 2D).
bFGF activated RhoA and Rac1, but not Cdc42
The small GTPases of the Rho family, namely, RhoA, Rac1,
and Cdc42, are the key regulators of cytoskeletal dynamics and cell
migration. To investigate the involvement of RhoA, Rac1, and
Cdc42 in bFGF-induced fibroblast migration, we measured the
activities of RhoA, Rac1, and Cdc42 in the fibroblasts treated with
bFGF (Figs. 3A, B, and C). As shown in Fig. 3A, RhoA activity
increased 5.7-fold at 15 min after bFGF stimulation, with peak
activation at 30 min and remained high for 60 min. Rac1 activity
increased 4.5-fold at 15 min after bFGF stimulation and remained
high for 60 min (Fig. 3B). However, Cdc42 activity did not
increase with bFGF treatment (Fig. 3C). These data show that
bFGF activated RhoA, Rac1, but not Cdc42.
Rac1, but not RhoA, was essential for bFGF-induced
fibroblast migration
Next, we examined how the inhibition of RhoA or Rac1 affects
fibroblast migration (Figs. 4C and E). To block RhoA or Rac1, we
used RNA interference with siRNA. As shown in Figs. 4A and B,
Figure 1. Number of the cells treated with each concentration
of mitomycin-C. (A) We counted the number of fibroblasts in a
microscopic counting chamber before or after treated with each
concentration of mitomycin-C (0, 1, 5 or 10 mg/ml) for 24 h. Mitomycin-
C at 0 or 1 mg/ml did not block cell proliferation. Mitomycin-C at 5 mg/
ml completely blocked cell proliferation, while Mitomycin-C at 10 mg/ml
was indicative of cellular cytotoxicity. (B) We counted the number of
fibroblasts before or after treated with 0 or 5 mg/ml mitomycin-C in the
presence of 100 ng/ml bFGF. Mitomycin-C at 5 mg/ml blocked bFGF-
induced fibroblast proliferation. Data are mean 6 s.e.m. of five
independent experiments. **P,0.01, as compared with the control
group (t test).
doi:10.1371/journal.pone.0012228.g001
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RhoA or Rac1 protein levels and did not show any activation in
response to bFGF stimulation.
The migration rate of RhoA-inhibited cells was similar to that of
the control cells during 12 h, regardless of the presence of bFGF
(Figs. 4C and D). In contrast, Rac1-inhibited cells showed a
reduction in the migration rate during 121 h (13.6961.75 mm/h)
as compared to the control cells in the presence of bFGF at
100 ng/ml (26.4861.34 mm/h) (Figs. 4E and F). Thus, inhibition
of RhoA did not affect bFGF-induced cell migration, whereas
inhibition of Rac1 blocked bFGF-induced cell migration signifi-
cantly. Furthermore, we investigated the effect of active Rac1
mutant on fibroblast migration. Figures 4G and H show that the
active Rac1-transfected cells had increased the migration rate
during 12 h (10.4160.79 mm/h) as compared to the control cells
in the absence of bFGF (6.2560.85 mm/h). These data suggest
that Rac1, but not RhoA, is essential for bFGF-induced fibroblast
migration.
The small GTPases of the Rho family can also affect cell shape
[6]. The cell shape of RhoA-inhibited cells changed to become
round with prominent dendritic processes (Fig. 4I). On the other
hand, the cell shape of Rac1-inhibited cells at the wound edge
showed less formation of lamellipodium (Fig. 4I).
Activation of PI3-kinase was involved in bFGF-induced
fibroblast migration
Chemotactic migration is regulated by phosphoinositide 3-
kinase (PI3-kinase) [25–28]. Therefore, we investigated the
involvement of PI3-kinase in bFGF-induced fibroblast migration.
Firstly, we measured the activation of the PI3-kinase effector Akt/
protein kinase B in response to bFGF stimulation (Fig. 5A).
Secondly, we performed a wound healing assay with LY294002, a
PI3-kinase inhibitor, to examine how the inhibition of PI3-kinase
affects fibroblast migration (Figs. 5B and C).
The relative level of the phosphorylated Akt increased at 30 min
after bFGF stimulation (Fig. 5A). These data indicate that bFGF
activated PI3-kinase and phosphorylated Akt. In the wound
healing assay (Figs. 5B and C), PI3-kinase-inhibited cells in the
presence of 100 ng/ml bFGF showed a reduction of migration
during 12 h (12.5060.54 mm/h) as compared to the control cells
in the presence of bFGF at 100 ng/ml (23.6161.76 mm/h). Thus,
inhibition of PI3-kinase blocked bFGF-induced cell migration
significantly. In addition, LY294002 inhibited bFGF-induced Akt
phosphorylation (Fig. 5A).
Activation of JNK is involved in bFGF-induced fibroblast
migration
Some recent studies have implicated the importance of the c-Jun
N-terminal kinase (JNK) pathway in regulation of cell migration
[29–32]. Therefore, we hypothesized that JNK is involved in bFGF-
induced fibroblast migration. To test this hypothesis, firstly, we
measured the phosphorylation of JNK in response to bFGF
stimulation (Fig. 6A). Secondly, we performed a wound healing
assay with SP600125, a JNK inhibitor (Figs. 6B and C).
As shown in Fig. 6A, the relative level of the phosphorylated
JNK increased at 30 min after bFGF stimulation, suggesting that
bFGF activated JNK. However, bFGF-induced JNK activation
was suppressed by SP600125 (Fig. 6A). In the wound healing assay
(Figs. 6B and C), JNK-inhibited cells showed a reduction in the
migration rate during 12 h in the presence of bFGF at 100 ng/ml
(7.2960.71 mm/h) as compared to the control cells
(25.0161.52 mm/h). Thus, inhibition of JNK blocked the bFGF-
induced cell migration significantly.
PI3-kinase contributed to bFGF-induced Rac1 activation
Rac1 reportedly acts as a downstream effector of PI3-kinase in
several growth factor-stimulated pathways [33]. Accordingly, we
measured the activation ofRac1 in fibroblasts treated with LY294002
in response to bFGF stimulation to examine whether PI3-kinase is
upstream of Rac1 in bFGF-induced fibroblast migration. The level of
Rac1-GTP showed a 45% reduction in the presence of LY294002
after bFGF stimulation (Fig. 7A), indicating that PI3-kinase
contributed to bFGF-induced Rac1 activation.
JNK was downstream of Rac1 in bFGF signaling
The activity of JNK is regulated by the small GTPases (Rac1
and Cdc42) [34], and Rac1 and JNK were also activated by bFGF
in this study (Figs. 3B and 6A). Consequently, we measured the
activation of JNK in the fibroblasts in the presence of Rac1 siRNA
after bFGF stimulation to examine whether JNK is downstream of
Rac1 in bFGF-induced migration signaling. As shown in Fig. 7B,
the level of the phosphorylated JNK showed a 71% reduction in
the presence of Rac1 siRNA. On the contrary, the active Rac1-
induced cells showed a 4.1-fold increase of JNK phosphorylation
as compared to the control cells (Fig. 7C). Finally, the cells treated
with LY294002 also showed a 58% reduction in the phosphor-
ylated JNK level (Fig. 7D). These data suggest that JNK was
downstream of Rac1 and PI3-kinase in the signal transduction
pathways of bFGF-induced fibroblast migration.
Discussion
Migration of dermal fibroblasts is crucial for skin wound repair.
Fibroblasts proliferate and migrate to the wound area, synthesize a
new extracellular matrix, and contribute to wound healing [35].
Previous studies showed that bFGF induced cell migration in some
cell types, such as the endothelial cells, keratinocytes, vascular
smooth muscle cells and fibroblasts [16,18–21,36–39,]. However,
the mechanism of bFGF-induced fibroblast migration is still
unclear. Herein, we investigated the mechanism of the fibroblast
migration by bFGF regardless of the effect on fibroblast
proliferation, and we noticed the involvement of the small
GTPases of the Rho family, PI3-kinase, and JNK.
Firstly, we demonstrated that the cells treated with bFGF at
each concentration increased the migration speed significantly in
the presence of mitomycin-C to block the cell proliferation
(Figs. 2A and B). Moreover, immunocytochemistry showed that
the bFGF-treated fibroblasts developed lamellipodial extension
after wounding (Figs. 2C and D). This lamellipodial extension
Figure 2. Effect of bFGF on fibroblast migration. (A) Wound healing assay in the fibroblasts treated with the indicated concentrations of bFGF
in the presence of 5 mg/ml mitomycin-C. This photograph shows the wounded cell monolayers at 0, 12, and 24 h after wounding in the absence or
presence of bFGF. The line indicates the wound edge at the start of the experiment (0 h). Bar =500 mm. (B) Analysis of the migration rate is expressed
as migration distance/time (mm/h). (C) Immunocytochemistry of the cells at the margin of the scratch wound with rhodamine-conjugated phalloidin
in the presence of 5 mg/ml mitomycin-C. This photograph shows the F-actin of the cell at 0, 1, 6, and 12 h after wounding with or without 100 ng/ml
bFGF. The bFGF-treated fibroblasts developed lamellipodial extension (arrowhead). Bar =50 or 10 mm (D) Lamellipodial extension was quantified by
summing the length of the outer margins of all lamellipodium in individual cells, and was expressed as a proportion of the total perimeter for each
cell (lamellipodial index). Data are mean 6 s.e.m. of five independent experiments. **P,0.01, as compared with the control group (t test).
doi:10.1371/journal.pone.0012228.g002
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cell migration [6]. Therefore, our data suggest that bFGF induced
lamellipodial extension of the fibroblasts and promoted migration.
Early changes in the actin cytoskeleton in the bFGF-mediated
scratch wound repair model were characterized by Wang and
Gotlieb in the endothelial cells [40]. They demonstrated that bFGF-
treated cells at the leading edge were more elongated and had more
prominent perpendicular actin microfilaments as compared to the
non-treated cells at 4 h after wounding. In our study, the bFGF-
treated fibroblasts showed more lamellipodial extension at 1 h after
wounding as compared to the control cells. Those cells at 6 h after
wounding showed more lamellipodial extension and increased
migration speed (Figs. 2C and D). Consistent with Wang and
Gotlieb’sfindings, we noticed that some of the cells treated by bFGF
developed perpendicular actin microfilaments. The endothelial cells
strongly bind with adjacent cells and migrate toward the wound as a
cluster. However, the fibroblasts do not bind with other cells, and
consequently migrate as individual cells (see Movie S2 in the
supporting information). Therefore, the fibroblasts can move omni-
directionally. This is presumably because the perpendicular actin
and elongated cells were seen in only some bFGF-treated
fibroblasts, not in all cells such as endothelial cells.
Secondly, we investigated which Rho GTPases, the key regulators
of these cytoskeletal dynamics [10,41,42], were involved in bFGF-
induced fibroblast migration. Our data demonstrated that bFGF
activated RhoA, Rac1, but not Cdc42 (Figs. 3A, B, and C). Welsh
et al. described the activation of Cdc42 by bFGF as well as integrins in
ha5-3T3 cells. The differences between Cdc42 activation by bFGF in
their study and in our study may be attributed to the differences of cell
type and coating material of the culture dish. We used primary rat skin
fibroblasts and plated them on a non-coated dish. However, Welsh
et al. used ha5-3T3 cells, stably expressing an a5h u m a nb1m o u s e
chimeric integrin, and plated the cells on a fibronectin-coated dish.
Previous studies showed that integrins could activate not only their
own downstream signals but also other growth factor receptors, such
as the receptors of PDGF, EGF, VEGF and FGF [43–50]. Integrins
and many growth factors can collaborate directly at the levels of
tyrosine kinase receptor phosphorylation and their downstream
signaling including small Rho GTPases [51–55]. Several reports also
provide evidence for direct crosstalk between bFGF and integrin a5b1
[49,50]. Therefore, bFGF-integrin cooperation may cause Cdc42
activation in ha5-3T3 cells on fibronectin-coated dishes.
Our data showed that inhibition of Rac1 blocked the bFGF-
induced cell migration significantly (Figs. 4E and F). Accordingly, we
concluded that Rac1 was involved in bFGF-induced fibroblast
migration. The contribution of RhoA and Rho-kinase, a down-
stream regulator of RhoA, to cellmigration depends on the celltypes
[56–60]. Several studies revealed that inhibition of RhoA/Rho-
kinase in the neutrophils and monocytes inhibited cell migration
[56,57]. On the other hand, inhibition of RhoA/Rho-kinase
promoted cell motility in other cell types; Swiss-3T3 cells, aortic
smooth muscle cells and focal adhesion kinase-null cells [58–60].
Our study demonstrated that inhibition of RhoA did not affect
bFGF-induced cell migration (Figs. 4C and D), while RhoA was also
activated by bFGF-stimulation (Fig. 3A). This is presumably because
of the balance between Rac1 and RhoA activation. Both Rac1 and
RhoA were activated in the bFGF pathway, but activation of Rac1
may be dominant to RhoA activation. Indeed, a previous study
revealed the importance of the balance between Rho GTPases in
determining the morphology of neurons, as their balance affects the
morphology of axons and dendrites, and spine growth [61].
PI3-kinase and JNK play important roles in the regulation of
cytoskeleton dynamics and cell migration [28–32,62–65]. Our study
demonstrated that bFGF activated PI3-kinase and JNK (Figs. 5A and
6A), and that their inhibition blocked bFGF-induced cell migration
significantly (Figs. 5C and 6C), suggesting that bFGF-induced
fibroblast migration requires PI3-kinase and JNK activation.
Figure 3. Activities of RhoA, Rac1, and Cdc42 by bFGF-
stimulation. (A)(B)(C) Activities in pull-down assays for RhoA, Rac1, and
Cdc42 were analyzed at 15, 30, and 60 min after 100 ng/ml bFGF-
stimulation in the presence of 5 mg/ml mitomycin-C. Densitometry for
RhoA, Rac1, and Cdc42-GTP was normalized to the amount of total RhoA,
Rac1, and Cdc42. Bradykinin treatment (100 ng/ml) for 10 min was
performed as a positive control of Cdc42 activation. The results are
presented as fold change as compared with fibroblasts in the absence of
bFGF. Data are mean 6 s.e.m. of three independent experiments.
**P,0.01, as compared with the control group (t test). brad.= bradykinin.
doi:10.1371/journal.pone.0012228.g003
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inhibitors of PI3-kinase block Rac1 activation [66–69]. Moreover,
previous studies suggested that the small GTPases Rac1 and
Cdc42 regulate the activity of JNK signaling [26,69]. Therefore,
we assumed that bFGF promoted fibroblast migration through the
PI3-kinase-Rac1-JNK pathway. Our data showed that inhibition
of PI3-kinase with LY294002 down-regulated the activities of
Rac1 and JNK via bFGF-stimulation (Figs. 7A and D), suggesting
that PI3-kinase contributed to bFGF-induced Rac1 and JNK
activation. Furthermore, inhibition of Rac1 by Rac1 siRNA down-
regulated JNK activation (Fig. 7B), while the constitutively active
Rac1-induction up-regulated JNK (Fig. 7C). These findings
suggest that JNK is the downstream of Rac1. Finally, we
concluded that bFGF promoted fibroblast migration through the
PI3-kinase-Rac1-JNK pathway, which is a novel pathway of
bFGF-induced cell migration (Fig. 8).
Materials and Methods
Cell culture
Primary skin fibroblasts were derived from rats aged 3 days. The
cells were cultured in Dulbecco’s Modified Eagle Medium
(DMEM) containing 10% fetal bovine serum (FBS), 100 U/ml
penicillin and 100 mg/ml streptomycin in a humidified incubator
at 37uC with 5% CO2 atmosphere. For experiments, the cells were
used between two and three passages. All animal experiments were
carried out in accordance with a protocol approved by the
Institutional Animal Care and Use Committee of Osaka
University (permit numbers, 21-012-0).
Cell proliferation assay
Second-passage fibroblasts were plated at a density of
2.43610
4 cells/ml on 35 mm dish and incubated for 24 h in
DMEM containing 10% FBS. Then, the cells were treated with
various concentrations of mitomycin-C (namely, 0, 1, 5, 10 mg/ml)
(Sigma Aldrich Japan, Tokyo, Japan) and incubated for 24 h in
DMEM containing 0.5% FBS in the absence or presence of
100 ng/ml bFGF (Kaken Pharmaceutical Co., Ltd., Tokyo,
Japan). The cells were detached by trypsinization, and the cell
number was counted using a microscopic counting chamber. Data
are mean 6 s.e.m. of five independent experiments. **P,0.01, as
compared with the control group (t test).
Wound healing assay
Confluent cells were cultured in DMEM containing 0.5% FBS
treated with 5 mg/ml mitomycin-C for 24 h and then wounded
with a linear scratch 500 mm by a sterile pipette tip. Images of the
Figure 4. Rac1, but not RhoA, was essential for bFGF-induced
fibroblast migration. (A)(B) Primary rat fibroblasts were transfected with
10 nM RhoA, 10 nM Rac1 siRNA or 10 nM nonspecific control pool siRNA.
Pull-downassaysforRhoAorRac1inthepresenceof5 mg/mlmitomycin-C
were performed after 48 h of siRNA treatment, using an immunoblot of
lysates for GAPDH to verify equal protein loading. (C)(E) Wound healing
assay containing 5 mg/ml mitomycin-C in fibroblasts transfected with
10 nM RhoA, 10 nM Rac1 siRNA or 10 nM nonspecific control pool siRNA
in the presence or absence of bFGF. Bar=500 mm. (D)(F)(H) Analysis of the
migration rate of the RhoA, Rac1-inhibited cells, or the active Rac1-
taransfected cells was performed. (G) Wound healing assay treated with
5 mg/ml mitomycin-C in fibroblasts transfected with 0.15 mg/cm
2 of
plasmid DNA (Rac1-61L) or empty vector as a control in the absence of
bFGF. (I) These images show the cell shape of the RhoA or Rac1-inhibited
cells at 24 h after wounding in the presence of 100 ng/ml bFGF.
Bar=50 mm. Data are mean 6 s.e.m. of five independent experiments.
*P,0.05, **P,0.01, as compared with the control group (t test).
doi:10.1371/journal.pone.0012228.g004
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IX70; Olympus, Tokyo, Japan) at 0, 12, and 24 h after wounding
and recorded for 24 h using a microscope (model IX-70;
Olympus) equipped with a CCD Camera (CoolSNAP HQ;
Nippon Roper, Chiba, Japan) and controlled by MetaMorph
software (Universal Imaging Co., Ltd., UK). All experiments were
Figure 5. Effect of inhibition of PI3-kinase on fibroblast migration. (A) The activity of Akt with or without 10 mM LY294002 was analyzed by
immunoblotting at 30 min after 100 ng/ml bFGF-stimulation in the presence of 5 mg/ml mitomycin-C. Densitometry for p-Akt was normalized to the
amount of Akt. The results are presented as fold change as compared with the fibroblasts in the absence of bFGF. (B) Wound healing assay containing
5 mg/ml mitomycin-C in fibroblasts treated with or without 10 mM LY294002 in the presence or absence of 100 ng/ml bFGF. Bar =500 mm. (C)
Analysis of the migration rate of PI3-kinase-inhibited cells was performed. Data are mean 6 s.e.m. of five independent experiments. **P,0.01, as
compared with the control group (t test).
doi:10.1371/journal.pone.0012228.g005
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cell proliferation. To observe the effect of bFGF on fibroblast
migration, the cells were treated with various concentrations of
bFGF (i.e., 0, 10, 100, 1000 ng/ml) just before wounding. To
observe the effects of RhoA or Rac1 inhibition, the cells were
treated with siRNA before the wounding. To observe the effects of
Figure 6. Effect of inhibition of JNK on fibroblast migration. (A) The activity of JNK with or without 10 mM SP600125 was analyzed by
immunoblotting at 30 min after 100 ng/ml bFGF-stimulation in the presence of 5 mg/ml mitomycin-C. Densitometry for p-JNK was normalized to the
amount of JNK. The results are presented as fold change as compared with fibroblasts in the absence of bFGF. (B) Wound healing assay containing
5 mg/ml mitomycin-C in fibroblasts treated with or without 10 mM SP600125 in the presence or absence of 100 ng/ml bFGF. Bar =500 mm. (C)
Analysis of the migration rate of JNK-inhibited cells was performed. Data are mean 6 s.e.m. of five independent experiments. *P,0.05, **P,0.01, as
compared with the control group (t test).
doi:10.1371/journal.pone.0012228.g006
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LY294002 (Jena Bioscience, Berlin, Germany) or 10 mM
SP600125 (Calbiochem, San Diego, USA) for 60 min before the
wounding. Twenty cells per one experiment (total 100 cells) at
the wound area were randomly selected. At 12 h after wounding
the distance between the selected 20 cells and wound edge at 0 h
was measured by using the functions of ‘‘measurement length’’ in
Image J software (National Institute of Health, Bethesda, MD,
USA). Migration rate was expressed as migration distance/time
(mm/h).
Immunofluorescence
The fibroblasts were maintained in DMEM containing 10%
FBS for 2 days and cultured in serum-free DMEM for 24 h.
Then, the cells treated with or without 100 ng/ml bFGF for 0, 1,
6, and 12 h after wounding in the presence of 5 mg/ml
mitomycin-C. The cells on coverslips were fixed with 4%
paraformaldehyde in PBS for 15 min and washed with PBS five
times. The cells were permeabilized with 0.3% Triton X-100 in
PBS for 10 min and incubated with 5% bovine serum albumin
(BSA) in PBS for 30 min to block nonspecific antibody binding.
Then cells were incubated with the Alexa Fluor 594 phalloidin
staining solution (5 U/ml, Invitrogen Japan, Tokyo, Japan) in
PBS containing 1% BSA for 20 min and washed with PBS for
30 min. The coverslips were mounted onto the slides using
VECTASHIELD Mounting Medium with DAPI (Vector Labo-
ratories, Peterborough, England). Fluorescence images were
taken using a confocal laser-scanning microscope (Axioplan2
LSM510; Carl Zeiss, Oberkochen, Germany). Lamellipodial
extension was quantified by summing the length of the outer
margins of all lamellipodium in individual cells. Each 20 cells per
one experiment at the wound area were randomly selected. The
perimeter of 100 ng/ml bFGF-treated cells or non-treated cells
was measured by using the functions of ‘‘measurement perime-
ter’’ in Image J software (National Institute of Health, Bethesda,
MD, USA). Lamellipodial index expressed as a proportion of the
total perimeter for each cell.
Western blot analysis and immunoprecipitation
The cells cultured in the presence of 5 mg/ml of mitomycin-C
were lysed in RIPA buffer containing 1 mM Na3VO4, 1 mM
NaF and Protease Inhibitor Cocktail (Roche Diagnostics, Basel,
Switzerland), incubated for 20 min at 4uC and centrifuged at
15,000 g for 15 min at 4uC. The proteins were separated on
SDS–PAGE and electrotransferred onto Immobilon-P Transfer
Membranes (MILLIPORE JAPAN, Tokyo, Japan). The mem-
branes were incubated in TBS containing 5% skim milk and
0.05% Tween-20 for 60 min and blotted with primary antibodies
at 4uC overnight. An anti-phospho-Akt antibody (1:1000, Cell
Signaling Technology, Massachusetts, USA), anti-Akt antibody
(1:1000, Cell Signaling Technology), anti-phospho-JNK antibody
Figure 7. PI3-kinase contributed to bFGF-induced Rac1 and
JNK activation. (A)(D) The activities of Rac1 or JNK in lysates of
fibroblasts treated with or without 10 mM LY294002 were analyzed at
15 min after 100 ng/ml bFGF-stimulation in the presence of 5 mg/ml
mitomycin-C. (B) The activity of JNK in lysates of fibroblasts transfected
with 10 nM Rac1 siRNA or 10 nM nonspecific control pool siRNA was
analyzed at 15 min after 100 ng/ml bFGF-stimulation in the presence of
5 mg/ml mitomycin-C. (C) The activity of JNK without bFGF in lysates of
fibroblasts transfected with 0.15 mg/cm
2 of plasmid DNA (Rac1-61L) or
empty vector as a control was analyzed in the presence of 5 mg/ml
mitomycin-C. Data are mean 6 s.e.m. of three independent experi-
ments. *P,0.05, **P,0.01, as compared with the control group (t test).
doi:10.1371/journal.pone.0012228.g007
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Cell Signaling Technology), anti-GAPDH antibody (1:2000,
Abcam, Cambridge, USA) and anti c-Myc antibody (1:100,
Santa cruz biotechnology, California, USA) were used as primary
antibodies. The membranes were incubated for 1 h with an anti-
mouse or anti-rabbit HRP-linked secondary antibody (1:2000,
Cell Signaling Technology). Reaction products were visualized by
detection of chemiluminescence using an ECL Western blotting
Detection System (GE Healthcare, Piscataway, NJ, USA).
Quantification of relative band densities was performed by
scanning densitometry using Image J software (National Institute
of Health, Bethesda, MD, USA).
RhoA, Rac1, Cdc42 pull-down assay
Pull-down assays for Rho-GTPases were performed as de-
scribed previously [66] with minor modifications. In brief, the cells
were scraped into ice-cold lysis buffer containing 50 mM Tris-
HCl, pH 7.4, 2 mM MgCl2, 1% NP-40, 10% glycerol, 100 mM
NaCl, and Protease Inhibitor Cocktail (Roche Diagnostics, Basel,
Switzerland) and centrifuged for 5 min at 14,000 g. The cleared
lysates were incubated with 20 mg PAK-1 PBD agarose (Cyto-
skeleton, Denver, USA) or 20 mg GST-tagged Rhotekin Rho-
binding domain bound to glutathione agarose (Cytoskeleton) for
60 min at 4uC. The beads were washed three times with lysis
buffer and heated for 5 min at 100uC in reducing SDS-PAGE
sample buffer, and then analyzed for bound RhoA, Rac1, and
Cdc42 molecules by Western blotting using anti-RhoA antibody
(1:200, Santa cruz biotechnology), anti-Rac1 antibody (1:500,
Cytoskeleton), anti-Cdc42 antibody (1:200, Santa cruz biotech-
nology). One hundred ng/ml bradykinin (Merck, Darmstadt,
Germany), a Cdc42 activator, was used to show endogenously
produced Cdc42-GTP.
RNA interference experiments
siRNA duplex for the RhoA or Rac1 gene was synthesized by
Invitrogen with help of the D-LUX Designer (Invitrogen Japan,
Tokyo, Japan). The RhoA siRNA (59-AUAAACCUCUGGGAA-
CUGGUCCUUG-39) was designed to target coding the region of
rat RhoA mRNA sequence (GenBank accession no. NM_057132).
The Rac1 siRNA (59-CAGAAUAGUUGUCAAAGACGGUGG-
G-39) was designed to target coding the region of rat Rac1 mRNA
sequence (GenBank accession no. NM_134366). Primary rat
fibroblasts were transfected with RhoA or Rac1 siRNA using
Lipofectamine RNAiMAX (Invitrogen Japan) and Opti-MEM
(Invitrogen Japan) by the manufacturer’s protocol. The final
concentration of siRNA was 10 nM. Stealth RNAi Negative
Control Medium GC Duplex (Invitrogen Japan) was used as a
control. The transfected cells were used for experiments after 48 h.
Transient transfections
Myc-tagged Rac1-61L in pEF-BOS was a gift from Dr. T.
Yamashita (Department of Molecular Neuroscience, Osaka
University Graduate School of Medicine, Osaka, Japan). For
transient transfection experiments, primary rat fibroblasts
60,80% confluent were transfected with 0.15 mg/cm
2 of plasmid
DNA (Rac1-61L) or empty vector (pEF-BOS) using Lipofecta-
mine2000 (Invitrogen Japan) and Opti-MEM (Invitrogen Japan)
by the manufacturer’s protocol. The transfected cells were used for
experiments after 48 h.
Supporting information
Images of the wounded cell monolayers were recorded for 24 h
using a microscope (model IX-70; Olympus) equipped with a
CCD Camera (CoolSNAP HQ; Nippon Roper) and controlled by
MetaMorph software (Universal Imaging Co., Ltd.). All videos
show time-lapse video recordings at 1 h intervals for 24 h. Movie
S1 shows primary rat fibroblast migrating for 24 h in the absence
of bFGF as a control. Movie S2 shows primary rat fibroblast
migrating for 24 h in the presence of 100 ng/ml bFGF.
Supporting Information
Movie S1 Fibroblast migration for 24 h in the absence of bFGF.
Time-lapse image of the wounded fibroblast monolayers was
recorded for 24 h in the absence of bFGF. Fibroblasts were treated
with 5 mg/ml mitomycin-C before the experiment.
Found at: doi:10.1371/journal.pone.0012228.s001 (5.06 MB AVI)
Figure 8. Signal transduction pathway of bFGF-stimulated
fibroblast migration. Activated FGFR stimulates PI3-kinase. Activa-
tion of PI3-kinase leads to up-regulation of Rac1, followed by the
activation of JNK, resulting in formation of lamellipodial extension.
doi:10.1371/journal.pone.0012228.g008
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bFGF. Time-lapse image of the wounded fibroblast monolayers
was recorded for 24 h after 100 ng/ml bFGF-stimulation.
Fibroblasts were treated with 5 mg/ml mitomycin-C before the
experiment.
Found at: doi:10.1371/journal.pone.0012228.s002 (6.39 MB AVI)
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